𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allogeneic and autologous bone marrow transplantation for acute leukemia and malignant lymphoma: Current status

✍ Scribed by F. B. Petersen; C. Dean Buckner

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
921 KB
Volume
5
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis

The current status of autologous and allogeneic marrow transplantation for acute leukemias and malignant lymphoma is reviewed and compared to the current status of conventional chemotherapy. Based on the reviewed literature, it is concluded that marrow transplantation and conventional chemoradiotherapy are not mutually exclusive and that for most young patients with acute hematological malignancies the question is not if, but rather when to intervene with a marrow transplant treatment. Thus marrow transplantation and conventional chemoradiotherapy can work as complimentary units in the complex therapeutic approach needed to cure most patients with hematological malignancies.

πŸ“œ SIMILAR VOLUMES

Autologous bone marrow transplantation w
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia
✍ Gonzales-Chambers, Rowena ;Przepiorka, Donna ;Shadduck, Richard K. ;Borochovitz, πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 512 KB

Ten patients age 13-52 years with acute lymphoblastic leukemia (ALL) in first complete remission (CR) (1), second CR (6), or relapse (3) were treated with cyclophosphamide 50 mg/kg daily x 4 and total body irradiation 3 Gy daily x 4 followed by infusion of autologous marrow purged with 4-hydroperoxy

Allogeneic bone marrow transplantation f
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experience
✍ W. Y. Au; A. K. W. Lie; S. K. Ma; L. C. Chan; C. K. Lee; Y. L. Kwong; C. S. Chim πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

Between 1990 and 1997, we performed 29 allogeneic BMTs for acute lymphoblastic leukemia (ALL) patients with HLA-identical sibs. Their median age was 31 years (range 15 to 43); there were 15 males and 14 females. The conditioning protocol was Cy-TBI (n=15), VP16-Cy-TBI(n=12), CBV (n=1) and Bu-Cy (n=1

Prediction of therapy-related acute myel
Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma
✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 269 KB πŸ‘ 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th

High-dose melphalan and autologous bone
High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemia
✍ Dominique Maraninchi; Manuel Abecasis; Jean-Albert Gastaut; GΓ©rard Sebahoun; Jea πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 246 KB

Seven patients with relapsed acute leukaemia were treated with high-dose melphalan (HDM) followed by the infusion of autologous cryopreserved remission marrow. Toxicy was minimal and all seven patients had a complete response. Four patients are still in unmaintained remission at 14, 13, 10, and 3 mo